1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Veerhealth Care Limited

Veerhealth Care Limited

VEERHEALTH.BO
Veerhealth Care LimitedIN flagBombay Stock Exchange
37.99
INR
+0.22
- -
759.74MMarket Cap
Veerhealth Care Limited
VEERHEALTH.BO
(Bombay Stock Exchange)

Recent

price

37.99

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
2.37
1.96
1.99
2.15
0.96
1.57
1.38
3.71
4.29
8.38
7.56
6.89
6.61
6.61
8.62
- -
16.38
Revenue per Share
-1.62
0.19
- -
0.02
0.04
0.01
0.02
0.1
0.11
0.23
0.27
-0.05
0.79
0.2
0.2
- -
0.27
Basic EPS, GAAP
-3.14
-0.16
-5.28
-0.64
-2.69
-0.55
1.19
-1.28
-0.15
-1.79
0.36
0.16
-1.39
1.04
-2.2
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.71
3.91
4.41
4.45
4.49
4.52
4.53
4.7
4.82
5.15
5.42
5.31
5.97
10.52
10.22
- -
10.08
Book Value per Share
7.18
7.38
9.16
9.19
9.23
9.25
9.27
9.45
9.58
9.92
10.13
10.06
10.72
10.92
11.35
- -
11.56
Tangible Book Value per Share
8
8
14
14
14
14
14
14
14
14
14
14
20
20
20
- -
20
Basic Weighted Avg Shares
18
15
28
30
13
22
19
51
59
116
105
96
132
132
169
325
325
Sales/Revenue/Turnover
-78.23
-1.78
-13.67
-15.61
-38.28
-9.49
-23
-6.18
6.33
3.06
-4.71
-11.36
1.4
-0.75
-0.82
3.6
3.6
Operating Margin (%)
- -
- -
- -
- -
1
1
2
3
3
3
5
5
6
7
9
13
13
Depreciation Expense
-12
1
- -
- -
1
- -
- -
1
2
3
4
-1
16
4
4
5
5
Net Income, GAAP
- -
30.08
- -
33.76
64.03
62.71
27.48
45.31
58.2
50.79
34.24
130.98
- -
68.32
36.96
56.75
56.76
Effective Tax Rate (%)
-68.4
9.89
0.23
0.86
4.27
0.41
1.19
2.67
2.66
2.74
3.62
-0.77
11.96
3.07
2.32
1.67
1.67
Profit Margin (%)
54
54
96
46
78
63
83
57
39
47
53
38
94
107
73
50
50
Working Capital
- -
- -
- -
- -
6
6
4
2
- -
20
14
- -
- -
- -
42
38
38
LT Debt
54
55
128
127
128
128
129
131
133
138
140
140
214
218
222
229
229
Total Equity
- -
-0.33
- -
-2.42
-1.38
-0.55
-2.4
-1.29
1.1
1.15
-2.02
2.24
- -
-0.14
-0.35
1.85
1.85
Return on Invested Capital (%)
- -
5.09
- -
0.42
1.01
0.8
1.43
2.53
2.23
4.41
5.49
-1.05
- -
2.48
2.43
2.9
2.82
Return on Capital (%)
-35.76
5.09
0.14
0.42
0.92
0.14
0.36
2.14
2.4
4.6
5.17
-0.99
16.38
2.46
1.91
2.72
2.63
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
8
LT Borrowings
45
- -
38
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
- -
20
Market Capitalization
347
384
399

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
70
- -
185
Cash, Cash Equivalents & STI
1
- -
5
Accounts Receivable, Net
19
- -
97
Inventories
27
- -
44
Total Current Liabilities
31
- -
134
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
8
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.89%
11.96%
3.17%
Free Cash Flow
-162.14%
-391.83%
-84.54%
Net Income, GAAP
-161.02%
-481.57%
38.95%
Sales/Revenue/Turnover
40.78%
29.94%
92.6%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36
38
29
29
132
2025
21
51
38
56
169
2026
45
40
73
168
325

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.17
0.19
0.09
- -
0.2
2025
0.06
0.15
0.04
-0.05
0.2
2026
0.12
0.13
0.2
-0.18
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Venus Remedies Limited (VENUSREM.BO)
Eton Pharmaceuticals, Inc. (ETON)
Bespoke Extracts, Inc. (BSPK)
PharmaSGP Holding SE (PSG.DE)
Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)
Hikma Pharmaceuticals PLC (HKMPY)
Business
Veerhealth Care Limited Veerhealth Care Limited (VEERHEALTH.BO) manufactures, markets, and trades research-based ayurvedic medicines, personal care, and oral care products in India. The company offers skincare products such as creams, lip balms, moisturizing lotions, face packs, rosewater, and scrubs; body care items including bodywash, bath salts, facewash, handwash, and soaps; haircare products comprising hair oils, shampoos, and conditioners; fragrances such as candles and body mists; healthcare solutions like pain relief oils, tablets, syrups, and sanitizers; oral care products including toothpastes; body and beard care items; gifting products; accessories; and combos such as haircare regimes and bath rituals. It also provides plastic bottles for industries including food, cosmetics, household cleaning, and pharmaceuticals, while selling products online and exporting to international markets including the United States. Incorporated in 1992 and headquartered in Mumbai, India, at 629-A Gazdar House, the company, formerly known as Niyati Leasing Limited, shifted from finance to pharmaceuticals in 2013 and entered cosmetic manufacturing in 2020. Recent developments include securing multiple export orders from a top US institutional supplier totaling over $350,000 in 2024 with expectations of monthly repeats; entering a strategic contract manufacturing agreement in 2025 with a leading Indian marketplace player in personal care for private-label production; announcing a Rs 33 crore expansion plan in February 2024 involving land acquisition, plant construction, and machinery procurement at its Vapi, Gujarat facility to achieve USFDA and WHO compliance; and targeting Rs 100 crore revenue within 2-3 years.